Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-11-23
2000-04-18
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 514343, 514382, 514456, 5462684, 5462831, 5462764, 548251, 549399, 549404, C07D31158, C07D40512, C07D40712, A61K 31353
Patent
active
060515864
ABSTRACT:
This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
REFERENCES:
patent: 3706764 (1972-12-01), Nakanishi et al.
patent: 3803176 (1974-04-01), Christensen et al.
patent: 4647579 (1987-03-01), Kabbe et al.
patent: 4650812 (1987-03-01), Cohen et al.
patent: 4654362 (1987-03-01), Van Lommen et al.
patent: 5393775 (1995-02-01), Le Baut et al.
patent: 5451677 (1995-09-01), Fisher et al.
patent: 5516917 (1996-05-01), Djuric et al.
patent: 5541197 (1996-07-01), Fisher et al.
patent: 5561142 (1996-10-01), Fisher et al.
patent: 5663194 (1997-09-01), Mewshaw
Silverman, Structure modifications to increase potency and Therapeutic Index, The Organic Chemistry of Drug Design and Drug Action, pp. 15-22, 1992.
Baryza Jeremy
Campbell Ann-Marie
Connell Richard D.
Cook James H.
Ladouceur Gaetan H.
Bayer Corporation
Brewer Alice A.
Rao Deepak R.
Shah Mukund J.
LandOfFree
Sulfonamide substituted chroman derivatives useful as beta 3 adr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide substituted chroman derivatives useful as beta 3 adr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide substituted chroman derivatives useful as beta 3 adr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336642